Article info

Download PDFPDF
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
  1. Dr J Askling, Clinical Epidemiology Unit, M9:01, Karolinska Institutet at Karolinska University Hospital, Solna, SE-171 76 Stockholm, Sweden; johan.askling{at}ki.se
View Full Text

Citation

Askling J, Baecklund E, Granath F, et al
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

Publication history

  • Accepted April 23, 2008
  • First published May 8, 2008.
Online issue publication 
April 14, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.